Page 5 - Pepgen Corporation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pepgen corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pepgen Corporation Today - Breaking & Trending Today

Research Analysts Offer Predictions for PepGen Inc.'s Q2 2022 Earnings (NASDAQ:PEPG)

PepGen Inc. (NASDAQ:PEPG – Get Rating) – Analysts at Wedbush issued their Q2 2022 EPS estimates for PepGen in a research report issued to clients and investors on Tuesday, May 31st. Wedbush analyst L. Chico anticipates that the company will post earnings per share of ($0.88) for the quarter. Wedbush has a “Outperform” rating and […] ....

United States , Stifel Nicolaus , Pepgen Company Profile Get Rating , Pepgen Inc , Get Rating , Gen Company Profile , Amgen Inc , Nasdaq Pepg , Earnings Estimates ,

PepGen IPO nabs $108M for muscular dystrophy drug with potential edge over Sarepta med

PepGen’s technology improves the delivery of a therapy to more tissue types and the clinical-stage biotech plans to use its IPO cash to continue developing its lead program for Duchenne muscular dystrophy. Meanwhile, eye products giant Bausch + Lomb returned to the public markets as a standalone company. Both the PepGen and Bausch + Lomb IPOs priced below their respective price ranges. ....

United Kingdom , Joe Papa , Matthew Wood , York Stock Exchange , Oxford Sciences Enterprises , University Of Oxford , Toronto Stock Exchange , Bausch Health Companies , Research Council Of United Kingdom , New York Stock Exchange , Valeant Pharmaceuticals , Oxford University , Bausch Health , Massachusetts Based Pepgen , Nasdaq Friday , Sarepta Therapeutics , Enhanced Delivery , Mike Gait , Medical Research Council , United Kingdom Research , Sciences Enterprises , Ontario Based Bausch , Toronto Stock , Weight Loss , Medical Devices , Healthcare Innovation ,